These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32062010)

  • 1. Developing polyphenolic acetates as radiation countermeasure agents: current status and future perspectives.
    Venkateswaran K; Shrivastava A; Prasad AK; Parmar VS; Dwarakanath BS
    Drug Discov Today; 2020 Apr; 25(4):781-786. PubMed ID: 32062010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitigation of radiation-induced hematopoietic injury by the polyphenolic acetate 7, 8-diacetoxy-4-methylthiocoumarin in mice.
    Venkateswaran K; Shrivastava A; Agrawala PK; Prasad A; Kalra N; Pandey PR; Manda K; Raj HG; Parmar VS; Dwarakanath BS
    Sci Rep; 2016 Nov; 6():37305. PubMed ID: 27849061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigation of radiation-induced gastro-intestinal injury by the polyphenolic acetate 7, 8-diacetoxy-4-methylthiocoumarin in mice.
    Venkateswaran K; Shrivastava A; Agrawala PK; Prasad AK; Devi SC; Manda K; Parmar VS; Dwarakanath BS
    Sci Rep; 2019 Oct; 9(1):14134. PubMed ID: 31575959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-modulation by 7, 8-diacetoxy-4-methylthiocoumarin in total body-irradiated mice: Implications for the mitigation of radiation-induced hematopoietic injury.
    Venkateswaran K; Shrivastava A; Agrawala PK; Prasad AK; Manda K; Parmar VS; Dwarakanath BS
    Life Sci; 2022 Dec; 311(Pt A):121140. PubMed ID: 36347324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Aftermath of Surviving Acute Radiation Hematopoietic Syndrome and its Mitigation.
    Micewicz ED; Iwamoto KS; Ratikan JA; Nguyen C; Xie MW; Cheng G; Boxx GM; Deriu E; Damoiseaux RD; Whitelegge JP; Ruchala PP; Avetisyan R; Jung ME; Lawson G; Nemeth E; Ganz T; Sayre JW; McBride WH; Schaue D
    Radiat Res; 2019 Apr; 191(4):323-334. PubMed ID: 30730284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives.
    Singh VK; Seed TM
    Expert Opin Investig Drugs; 2023 Jan; 32(1):25-35. PubMed ID: 36655861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation countermeasure agents: an update (2011-2014).
    Singh VK; Newman VL; Romaine PL; Wise SY; Seed TM
    Expert Opin Ther Pat; 2014 Nov; 24(11):1229-55. PubMed ID: 25315070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain-dependent Manner in Mice.
    Daniel AR; Lee CL; Oh P; Luo L; Ma Y; Kirsch DG
    Health Phys; 2020 Sep; 119(3):315-321. PubMed ID: 32175929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure.
    Singh VK; Seed TM
    Expert Opin Investig Drugs; 2020 May; 29(5):429-441. PubMed ID: 32450051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.
    MacVittie TJ; Bennett AW; Farese AM; Taylor-Howell C; Smith CP; Gibbs AM; Prado K; Jackson W
    Health Phys; 2015 Nov; 109(5):427-39. PubMed ID: 26425903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in medical countermeasure development against acute radiation exposure based on the US FDA animal rule.
    MacVittie TJ; Farese AM
    J Radiol Prot; 2021 Nov; 41(4):. PubMed ID: 34433144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further Characterization of Multi-Organ DEARE and Protection by 16,16 Dimethyl Prostaglandin E2 in a Mouse Model of the Hematopoietic Acute Radiation Syndrome.
    Wu T; Pelus LM; Plett PA; Sampson CH; Chua HL; Fisher A; Feng H; Liu L; Li H; Ortiz M; Chittajallu S; Luo Q; Bhatwadekar AD; Meyer TB; Zhang X; Zhou D; Fischer KD; McKinzie DL; Miller SJ; Orschell CM
    Radiat Res; 2023 May; 199(5):468-489. PubMed ID: 37014943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice.
    Singh VK; Fatanmi OO; Wise SY; Carpenter A; Nakamura-Peek S; Serebrenik AA; Kaytor MD
    Int J Radiat Biol; 2022; 98(5):958-967. PubMed ID: 34554032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary Promising Findings for Manganese Chloride as a Novel Radiation Countermeasure Against Acute Radiation Syndrome.
    Hood MN; Ayompe E; Holmes-Hampton GP; Korotcov A; Wuddie K; Aschenake Z; Ahmed AE; Creavalle M; Knollmann-Ritschel B
    Mil Med; 2024 Aug; 189(Suppl 3):598-607. PubMed ID: 39160887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation.
    McCart EA; Lee YH; Jha J; Mungunsukh O; Rittase WB; Summers TA; Muir J; Day RM
    Sci Rep; 2019 Feb; 9(1):2198. PubMed ID: 30778109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice.
    Sundaramoorthy P; Wang Q; Zheng Z; Jiao Y; Chen BJ; Doan PL; Chao NJ; Kang Y
    Stem Cell Res Ther; 2017 Nov; 8(1):263. PubMed ID: 29141658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat Models of Partial-body Irradiation with Bone Marrow-sparing (Leg-out PBI) Designed for FDA Approval of Countermeasures for Mitigation of Acute and Delayed Injuries by Radiation.
    Fish BL; MacVittie TJ; Gao F; Narayanan J; Gasperetti T; Scholler D; Sheinin Y; Himburg HA; Hart B; Medhora M
    Health Phys; 2021 Oct; 121(4):419-433. PubMed ID: 34546222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-(4-nitrobenzenesulfonyl)-4-penylpiperazine increases the number of Peyer's patch-associated regenerating crypts in the small intestines after radiation injury.
    Bhat K; Duhachek-Muggy S; Ramanathan R; Saki M; Alli C; Medina P; Damoiseaux R; Whitelegge J; McBride WH; Schaue D; Vlashi E; Pajonk F
    Radiother Oncol; 2019 Mar; 132():8-15. PubMed ID: 30825974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP Inhibitor Ilomastat Improves Survival of Mice Exposed to γ-Irradiation.
    Li XM; Tan Y; Huang CQ; Xu MC; Li Q; Pan D; Zhao BQ; Hu BR
    Biomed Environ Sci; 2018 Jun; 31(6):467-472. PubMed ID: 30025561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery strategies for acute radiation syndrome.
    Singh VK; Seed TM; Olabisi AO
    Expert Opin Drug Discov; 2019 Jul; 14(7):701-715. PubMed ID: 31008662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.